---
schema_version: "secwatch.filing_event.v1"
accession: "0001737287-23-000023"
form_type: "8-K"
ticker: "ALLO"
cik: "0001737287"
company_name: "Allogene Therapeutics, Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:39:29.570399+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Allogene Therapeutics has no cash deposits or securities at Silicon Valley Bank

## Summary
- Company confirms zero exposure to SVB amid its closure and industry uncertainty.
- No cash or securities held at SVB; no financial impact from the bank's collapse.
- Disclosure aims to address investor concerns about counterparty risk.

## SEC filing metadata
- accession: 0001737287-23-000023
- form_type: 8-K
- ticker: ALLO
- cik: 0001737287
- company_name: Allogene Therapeutics, Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737287/000173728723000023/0001737287-23-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737287/000173728723000023/allo-20230310.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001737287-23-000023
- JSON: https://secwatch.observer/filing/0001737287-23-000023.json
- Plain text: https://secwatch.observer/filing/0001737287-23-000023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.